The Recall Desk

State

Kansas product recalls

73,833 recalls have nationwide distribution and so reach Kansas. 5,822 additional recalls listed Kansas specifically in their distribution scope.

What the numbers show

Total
5,822
Critical
1,053
Severe
1,486
Most recent
2026-11-04

Of the 5,822 recalls naming Kansas we have scored against our rubric, 1,053 (18%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,486 (26%) are Severe.

These figures cover only the 5,822 recalls whose distribution notice names Kansas specifically. The 73,833 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

59326–59350 of 79655

  • HighFDA (Devices)·Z-1482-2015·2015-04-29

    Wright Medical Recalls Crosscheck Plating System Due to Spec Failures

    Wright Medical Technology is recalling 51 units of the Crosscheck Plating System because dimensional specifications are out of range, posing a risk of intraoperative malfunction.

    Product
    CROSSCHECK(R) Plating system, HOCKEY STICK CX Plate, Left, REF CCP-HSX1L. Orthopedic use.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-652-2015·2015-04-29

    Attix Pharmaceuticals Recalls Estradiol Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Estradiol active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Estradiol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-695-2015·2015-04-29

    Attix Pharmaceuticals Recalls Furosemide Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling furosemide active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Furosemide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1468-2015·2015-04-29

    Churchill Medical Systems Recalls Bifurcated Extension Sets Due to Leaking Risk

    Churchill Medical Systems is recalling 100 Bifurcated Extension Sets because a defect may cause leaking. The sets are used to administer medical fluids.

    Product
    Bifircated Extension Set, Product Code: BN-828 Accessory device used to administer medical fluids
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-492-2015·2015-04-29

    Attix Pharmaceuticals Recalls 4-Aminopyridine Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling 4-Aminopyridine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    4-Aminopyridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1493-2015·2015-04-29

    Wright Medical Recalls Crosscheck Plating System Due to Specification Defects

    Wright Medical Technology is recalling 172 units of the Crosscheck Plating System because specific dimensions are out of specification, posing a risk of intraoperative malfunction.

    Product
    CROSSCHECK(R) Plating system, MTP CX Plate, Right, REF CCP-MPX1R. Orthopedic use.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-939-2015·2015-04-29

    Tranilast API Recalled for Potential Penicillin Cross-Contamination

    Attix Pharmaceuticals is recalling Tranilast active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Tranilast active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-670-2015·2015-04-29

    Ezetimibe API Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling Ezetimibe active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Ezetimibe active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-543-2015·2015-04-29

    Attix Pharmaceuticals Recalls Bimatoprost API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Bimatoprost active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Bimatoprost active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-507-2015·2015-04-29

    Aldosterone API Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling Aldosterone active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Aldosterone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-936-2015·2015-04-29

    Attix Pharmaceuticals Recalls Topiramate API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Topiramate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Topiramate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-631-2015·2015-04-29

    Attix Pharmaceuticals Recalls Dimethyl Fumarate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Dimethyl Fumarate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Dimethyl Fumarate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-644-2015·2015-04-29

    Attix Pharmaceuticals Recalls D-Penicillamine Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling D-Penicillamine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    D-Penicillamine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-734-2015·2015-04-29

    Irbesartan API Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling Irbesartan active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Irbesartan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1469-2015·2015-04-29

    Churchill Medical Systems Recalls 4-inch Microbore Double Lumen Sets

    Churchill Medical Systems is recalling 2,350 units of 4-inch Microbore Double Lumen Sets due to a potential leak caused by an insufficient bond between the needleless device and the female luer.

    Product
    4" Microbore Double Lumen Set with Bionector, Product Code: BN-208 Accessory device used to administer medical fluids
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1483-2015·2015-04-29

    Wright Medical Recalls Crosscheck Plating System Due to Dimensional Defects

    Wright Medical Technology is recalling 52 units of the Crosscheck Plating System because dimensional specifications are out of range, posing a risk of intraoperative malfunction.

    Product
    CROSSCHECK(R) Plating system, HOCKEY STICK CX Plate, Right, REF CCP-HSX1R. Orthopedic use.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-940-2015·2015-04-29

    Trazodone HCl Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling Trazodone HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Trazodone HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-598-2015·2015-04-29

    Attix Pharmaceuticals Recalls Clozapine API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling all lots of Clozapine active pharmaceutical ingredient repackaged between January 2012 and February 2015 due to potential penicillin cross-contamination.

    Product
    Clozapine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-502-2015·2015-04-29

    Adapalene API Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling all lots of Adapalene active pharmaceutical ingredient distributed between January 2012 and February 2015 due to potential penicillin cross-contamination.

    Product
    Adapalene active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-551-2015·2015-04-29

    Attix Pharmaceuticals Recalls Bupivacaine Ingredient Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Bupivacaine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging. The product was distributed nationwide to compounding pharmacies and research organizations.

    Product
    Bupivacaine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1473-2015·2015-04-29

    Churchill Medical Systems Recalls 7-Inch High Pressure Sets Due to Leaking Risk

    Churchill Medical Systems is recalling 129,500 units of 7-inch High Pressure Sets with Bionector due to a potential for leaking caused by insufficient bonding.

    Product
    7" High Pressure Set with Bionector, Product Code: CMS-808 and CMS-808-1 Accessory device used to administer medical fluids
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-808-2015·2015-04-29

    Attix Pharmaceuticals Recalls Moxifloxacin HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Moxifloxacin HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Moxifloxacin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-614-2015·2015-04-29

    Attix Pharmaceuticals Recalls Dapsone API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Dapsone active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Dapsone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-582-2015·2015-04-29

    Cholestyramine API Recalled for Potential Penicillin Cross-Contamination

    Attix Pharmaceuticals is recalling Cholestyramine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Cholestyramine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-506-2015·2015-04-29

    Attix Pharmaceuticals Recalls Albuterol Sulfate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Albuterol Sulfate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Albuterol Sulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide